Severe liver disease is caused by HBV rather than HCV in children with hematological malignancies

Hematology Journal

Volumn 4, Issue 5, 2003, Pages 321-327

  El Sayed, Manal H ^a   Mohamed, Magdy M ^b   Karim, Amr ^b   Maina, Anna Maria ^c   Oliveri, Filippo ^c   Brunetto, Maurizia Rossana ^c   Bonino, Ferruccio ^d  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b Ain Shams University   (Egypt)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Children; Fulminant hepatitis; Hematological malignancies; Hepatitis B; Hepatitis C

Indexed keywords

AMINOTRANSFERASE; ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; METHOTREXATE; VIRUS DNA; VIRUS RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BRAIN DISEASE; CANCER CHEMOTHERAPY; CAUSE OF DEATH; CHILD; COMORBIDITY; CONTROLLED STUDY; DEATH; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GENOTYPE; HEMATOLOGIC MALIGNANCY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HODGKIN DISEASE; HUMAN; INCIDENCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER DYSFUNCTION; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; SCREENING; STATISTICAL ANALYSIS; SUPERINFECTION; THALASSEMIA MAJOR; VIRUS CARRIER;

ADOLESCENT; ANTIGENS, VIRAL; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; HEMATOLOGIC NEOPLASMS; HEPATITIS B; HEPATITIS C; HUMANS; LIVER DISEASES; MALE; MASS SCREENING; PREVALENCE; PROSPECTIVE STUDIES; THALASSEMIA; VIRUS ACTIVATION;

EID: 0141960142     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200300     Document Type: Article

References (48)

1. Januszkiewicz D, Wysocki J, Nowak J. Hepatitis B and C virus infection in Polish children with malignancies. Eur J Pediatr 1997; 156: 454-456.
2. Sevinir B, Meral A, Gunay U, Ozkan T, Ozuysal S, Sinirtas M. Increased risk of chronic hepatitis in children with cancer. Med Pediatr Oncol 2003; 40: 104-110.
3. Lok ASF, Liang RHS, Chin EKW, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100: 182-188.
4. Soh LT, Ang PT, Sng I, Chua EJ, Ong YW. Fulminant hepatic failure in non-Hodgkin's lymphoma patients treated with chemotherapy. Eur J Cancer 1992; 28A: 1338-1339.
5. Fan F, Tzeng CH, Hsiao KI, Hu ST, Liu WT, Chen PM. Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transplant 1991; 8: 417-420.
6. Gruber A, Lundberg LG, Bjorkholm M. Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy. J Intern Med 1993; 234: 223-225.
7. Repp R, von Horsten B, Fischer HP, Gerlich HP, Lampert F. Hepatitis B virus infection in children with cancer. Pediatr Infect Dis J 1993; 12: 620-621.
8. Saif MW, Little RF, Hamilton JM, Allegra CJ, Wilson WH. Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: a case report and review of literature. Ann Oncol 2001; 12: 123-129.
9. Nakamura Y, Motokura T, Fujita A. Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Cancer 1996; 78: 2210-2215.
10. Zuckerman E, Zuckerman T, Douer D, Qian D, Levine AM. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer 1998; 83: 1224-1230.
11. Kawatani T, Suou T, Tajima F, Ishiga K, Omura H, Endo A et al. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies. Eur J Haematol 2001; 67: 45-50.
12. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2001; 34: 1225-1241.
13. Brunetto MR, Giarin E, Oliveri F, Chiaberge E, Baldi M, Alfarano A et al. Wild-type and "e" antigen-minus hepatitis viruses and course of chronic hepatitis. Proc Natl Acad Sci USA 1991; 88: 4186-4190.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
15. Lazizi Y, El-Fassi E, Pillot J. Detection of hepatitis C virus sequences in sera with controversial serology by nested polymerase chain reaction. J Clin Microbiol 1992; 30: 931-934.
16. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
17. Utili R, Zampino R, Bellopede P, Marracino M, Ragone E, Adinolfi LE et al. Dual or single Hepatitis B and C virus infections in childhood cancer survivors: long-term follow-up and effect of interferon treatment. Blood 1999; 94: 4046-4052.
18. Khalifa AS, Mitchell BS, Watts DM, El-Samahy MH, El-Sayed MH, Hassan NF et al. Prevalence of hepatitis C viral antibody in transfused and non-transfused Egyptian children. Am J Tropic Med Hyg 1993; 49: 316-321.
19. Meir H, Balawi I, Nayel H, El Karaksy H, El Haddad A. Hepatic dysfunction in children with acute lymphoblastic leukemia in remission: relation to hepatitis infection. Med Pediatr Oncol 2001; 36: 469-473.
20. Abdel-Wahab MF, Zakaria S, Kamel M, Abdel-Khaliq MK, Mabrouk MA, Salama H et al. High seroprevalence of hepatitis C infection among risk groups in Egypt. Am J Tropic Med Hyg 1994; 51: 563-567.
21. Arthur RR, Hassan NF, Abdallah MY, El-Sharkawy MS, Saad MD, Hakbart BG et al. Hepatitis C anti-body prevalence in blood donors in different governerates in Egypt. Trans R Soc Tropic Med Hyg 1997; 91: 271-274.
22. Mahoney FJ. Update on diagnosis management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999; 12: 351-366.
23. Kuniyoshi M, Nakamuta M, Sakai H, Kuniyoshi M, Nakamuta M, Sakai H et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol 2001; 16: 215-219.
24. Willers E, Webber L, Delport R, Kruger M. Hepatitis B - a major threat to childhood survivors of leukaemia/lymphoma. J Tropic Pediatr 2001; 47: 220-225.
25. Kocabas E, Aksaray N, Alhan E, Tanyeli A, Koksal F, Yarkin F. Hepatitis B and C virus infections in Turkish children with cancer. Eur J Epidemiol 1997; 113: 869-873.
26. Styczynski J, Wysocki M, Koltan S, Kurylak A. Epidemiologic aspects and preventive strategy of hepatitis B and C viral infections in children with cancer. Pediatr Infect Dis J 2001; 20: 1042-1049.
27. Allander T, Gruber A, Naghavi M. Frequent patient-to-patient transmission of hepatitis C virus in a hematology ward. Lancet 1995; 345: 603-606.
28. Locasciulli A, Testa M, Valsecchi MG, Bacigalupo A, Solinas S, Tomas JF et al. on behalf of the Infectious Diseases-Working Party of the European Blood and Marrow Transplantation Group. The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogenic BMT: a prospective study by the infectious disease working party of the European Blood and Marrow Transplantation Group. Transplantation 1999; 68: 1486-1491.
29. Markovic S, Drozina G, Vovk M, Fidler-Jenko M. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients. Hepatogastroenterology 1999; 46: 2925-2930.
30. Faggioli P, De Paschale M, Tocci A, Luoni M, Fava S, De Paoli A et al. Acute hepatic toxicity during cyclic chemotherapy in non-Hodgkin's lymphoma. Haematologica 1997; 82: 38-42.
31. Kumagai K, Takagi T, Nakamura S, Sawada U, Kura Y, Kodama F et al. Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan. Ann Oncol 1997; 8: 107-109.
32. Yeo W, Chan PK, Zhong S, Ho WM, Steinberg JL, Tam JS et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol 2000; 69: 299-307.
33. Marusawa H, Imoto S, Udea Y, Chiba T. Reactivation of latently infected hepatitis B virus in leukemia patients with antibodies to hepatitis core antigen. J Gastroenetrol 2001; 36: 633-636.
34. Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol 2002; 17: 643-650.
35. Conjeevaram HS, Lok ASF. Management of chronic hepatitis. J Hepatol 2003; 38: S90-S103.
36. Hoofnagle JH, Dusheiko GM, Schafer DF. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96: 447-449.
37. Thung SN, Gerber MA, Klion F, Gilbert H. Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier. Arch Intern Med 1985; 145: 1313-1314.
38. Perrillo RP. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2002; 120: 1009-1022.
39. Simini B. Italian outbreak of fulminant hepatitis B reported. Lancet 1998; 351: 653.
40. Petrosillo N, Ippolito G, Solforosi L, Varaldo PE, Clementi M, Manzin A. Molecular epidemiology of an outbreak of fulminant hepatitis B. J Clin Microbiol 2000; 38: 2975-2981.
41. Locasciulli A, Mura R, Fraschini D, Gornati G, Scovena E, Gervasoni A et al. High-dose methotrexate administration and acute liver damage in children treated for acute lymphoblastic leukemia. A prospective study. Haematologica 1992; 77: 49-53.
42. Farrow AC, Buchanan GR, Zwiener RJ, Bowman WP, Winick NJ. Serum aminotransferase elevation during and following treatment of childhood acute lymphoblastic leukemia. J Clin Oncol 1997; 15: 1560-1566.
43. Chu CM, Yeh CT, Liaw YF. Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus. Gut 1999; 45: 613-617.
44. Jain A, Kar P, Madan K, Das UP, Budhiraja S, Gopalkrishna V et al. Hepatitis C virus infection in sporadic fulminant viral hepatitis in North India: cause or co-factor? Eur J Gastroenterol Hepatol 1999; 11: 1231-1237.
45. Keeffe EB. End-stage liver disease and liver transplantation: role of lamivudine therapy in patients with chronic hepatitis B. J Med Virol 2000; 61: 403-408.
46. Papatheodoridis GV, Davies S, Dhillon AP, Teixeira R, Goulis J, Davidson B et al. The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis. Transplantation 2001; 72: 412-418.
47. Ljungman P, Johansson N, Aschan J, Glaumann H, Lonnqvist B, Ringden O et al. Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood 1995; 86: 1614-1618.
48. Strasser SI, Sullivan KM, Myerson D, Spurgeon CL, Storer B, Schoch HG et al. Cirrhosis of the liver in long-term marrow transplant survivors. Blood 1999; 93: 2359-2366.